SCHEMBL24379670

SCHEMBL24379670

CCOC(=O)C1=C(O)C(=O)N(CC2CCN(C(=O)OC(C)(C)C)C2)C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADORA1 P30542 1/20 0.38
GPR119 Q8TDV5 2/20 0.38
FEN1 P39748 1/20 0.38
FPR2 P25090 1/20 0.37
TP53 P04637 2/20 0.37
KDM4E B2RXH2 2/20 0.36
PKM P14618 1/20 0.36
NOTCH1 P46531 1/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
PIK3CD O00329 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23918539 0.94 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL23918744 0.83 MEN1 (0.39) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL23918734 0.82 TP53 (0.43) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL23918383 0.80 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL24379683 0.80 MEN1 (0.43) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL23918731 0.80 MEN1 (0.43) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL24379692 0.77 ADORA1 (0.40) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL23918385 0.75 GLA (0.39) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL23918716 0.74 MEN1 (0.42) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL23918370 0.73 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AFEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319324-B2 Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors BAYER AKTIENGESELLSCHAFT (DE) 2022-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319324-B2 Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors P2RX3, P2RX1, P2RX5 ALDH1A1 1120/4885MEN1 2887/4885KMT2A 4618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.